NEW YORK (GenomeWeb News) — Cell Projects today said it has purchased DNA-handling company Isohelix for an undisclosed sum.
 
Cell Projects specializes in PCR, DNA sample-handling, and electroporation. Isohelix makes DNA buccal swab devices and isolation kits that Cell Projects said increase uptake and reduce breakdown of DNA.   
 
Under the terms of the deal, the entire Isohelix business will be integrated with Cell Projects’ facility in Maidstone Kent, UK.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.